Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
PCGRINT
Stock Latest News
Private Companies
GRIN Therapeutics Highlights Progress in Phase 3 GRIN-NDD Program and Advocacy-Driven R&D Strategy
1d ago
GRINT
Premium
Private Companies
GRIN Therapeutics Highlights Progress in Phase 3 Beeline Trial and Patient-Centric Strategy
1d ago
GRINT
Premium
Private Companies
GRIN Therapeutics Advances Late-Stage GRIN-NDD Trial and Expands Rare CNS Pipeline
4d ago
GRINT
Premium
Private Companies
Advancing Late-Stage Trials in Rare Neurodevelopmental Disorders
6d ago
GRINT
Premium
Private Companies
GRIN Therapeutics Advances Phase 3 GRIN-NDD Program and Deepens Rare Disease Engagement
11d ago
GRINT
Premium
Private Companies
GRIN Therapeutics Highlights Focus on Tuberous Sclerosis and Rare Neurodevelopmental Needs
11d ago
GRINT
Premium
Private Companies
GRIN Therapeutics Emphasizes Unmet Needs in Tuberous Sclerosis and Rare Neurodevelopmental Disorders
11d ago
GRINT
Premium
Private Companies
GRIN Therapeutics Highlights Progress of Phase 3 Beeline Trial for GRIN-NDD
13d ago
GRINT
Premium
Private Companies
GRIN Therapeutics Highlights Phase 3 Beeline Trial and Patient Engagement in GRIN-NDD
13d ago
GRINT
Premium
Private Companies
Conference Engagement Underscores GRIN Therapeutics’ Focus on GRIN-Related Neurodevelopmental Disorder
15d ago
GRINT
Premium
Private Companies
Conference Participation Underscores GRIN Therapeutics’ Focus on GRIN-NDD Pipeline
15d ago
GRINT
Premium
Private Companies
GRIN Therapeutics Expands Phase 3 Trial and Reinforces Focus on Rare Neurodevelopmental Disorders
18d ago
GRINT
Premium
Private Companies
GRIN Therapeutics Emphasizes Tuberous Sclerosis Focus and Neurodevelopmental R&D Strategy
20d ago
GRINT
Premium
Private Companies
GRIN Therapeutics Emphasizes Focus on Tuberous Sclerosis Complex and Neurodevelopmental R&D
20d ago
GRINT
Premium
Private Companies
GRIN Therapeutics Expands Pivotal Phase 3 Beeline Trial to Europe
22d ago
GRINT
Premium
Private Companies
GRIN Therapeutics Expands Phase 3 Beeline Trial for Radiprodil to Europe
23d ago
GRINT
Premium
Private Companies
GRIN Therapeutics Inc – Weekly Recap
25d ago
GRINT
Premium
Private Companies
Patient-Centered Outcome Measures Advance GRIN Therapeutics’ GRIN-NDD Program
29d ago
GRINT
Premium
Private Companies
Patient-Centered Outcome Measures Advance GRIN Therapeutics’ GRIN-NDD Strategy
29d ago
GRINT
Premium
Private Companies
GRIN Therapeutics Highlights Partnerships in Rare Disease Diagnostic Ecosystem
1M ago
GRINT
Premium
Private Companies
GRIN Therapeutics Emphasizes Rare-Disease Diagnostics and Partnerships
1M ago
GRINT
Premium
Private Companies
GRIN Therapeutics Highlights Progress of Phase 3 Beeline Trial for GRIN-NDD
1M ago
GRINT
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
